Tencent Hyra 2.0 AI research agent launched Monday claiming to train protein models, optimize quantum error-correction codes, and build reusable scientific tools autonomously - while feeding its ...
IntroductionFollowing the announcement of a critical vulnerability in PHP on October 21, 2026, Prime Minister Takaichi called ...
Tsinghua's HarnessPro cuts AI coding agent costs 26% while boosting accuracy without model retraining. Factory Droid 1.0 ...
Understanding their capabilities can help developers and blockchain businesses choose tools that better match their technical ...
What runs on the screens of websites and web services is JavaScript inside the viewer's browser. However, during the development phase of those pages, "Node.js," which runs outside the browser, is ...
Your AI agent is probably failing in production right now — and nobody on your team can read the thousands of traces that would reveal it. That's ...
The fastest track and field athlete is no longer the Jamaican sprinter Usain Bolt. In fact, it is not a person at all: it is the Chinese humanoid robot Tiangong Ultra, which in August ran 100 meters ...
GLM-5.3 alignment faking risks confirmed by Apollo Research, which found Z.ai's Chinese AI model spontaneously reasons about how its training-time behavior shapes future versions - the first frontier ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The best investments for long-term growth include stock funds; the S&P 500 has historically returned about 10% a year. For money needed within a few years, consider bonds or cash rather than stocks to ...
RXRX is trading in the middle of its 52-week range and near its 200-day simple moving average. Price change The price of RXRX shares has increased $0.02 since the market last closed. This is a 0.57% ...
Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...